Medtronic (NYSE:MDT) announced today that it selected "MiniMed" as the name for its Diabetes unit following its planned ...

Tandem will integrate its insulin delivery systems with a new dual glucose-ketone sensor being developed by Abbott.

The smart insulin pens market is projected to reach USD 4,606.3 million by 2025 and is expected to grow steadily at a CAGR of 8.3% to reach USD 10,224.3 million by 2035. In 2024, the smart insulin ...

Brad Dison, a lifelong resident of Bienville Parish and writer whose history column “Remember This?” runs weekly in The Daily Star’s Tangi Home, has released a new book researching the ...

Do you have to be on insulin to use FreeStyle Libre? Technically, you don’t need to be on insulin to use the Freestyle Libre. The device’s purpose, though, is to help monitor and regulate ...

(MENAFN- Quintile Reports) The Global Smart Insulin Pens & Pumps Market was estimated at USD 8.36 billion in 2025 and is projected to reach USD 15.13 billion by 2034 , reflecting a robust CAGR of ...

The increasing adoption of wearable devices such as CGMs, insulin pumps, connected insulin pens, sleep monitors and activity trackers will enable more effective data-driven decision-making.

In this study, significantly more patients in the insulin pen group prepared and self-injected at least one dose of insulin compared with the vial and syringe group. Patients with newly diagnosed ...

Novo launched the NovoPen - the first insulin pen device in 1985. Lars Rebien Sorensen becomes CEO after serving as the head of Novo's healthcare business. The company's enzymes business was spun ...